A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Sotagliflozin (INPEFA)

Sodium-Glucose Cotransporter 2 Inhibitor class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2023-05-26
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$9.3M in CY2024 Part D spend12K claims · 3K beneficiaries · 329 plans surveyed

Lowest NADAC
$20.34/unit
2 NDCs benchmarked, lowest of all strengths.
Average NADAC
$20.34
Across all dosage forms in distribution.
Highest NADAC
$20.34
Range is tight.
Plans with PA
36 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Sotagliflozin used for?

Sotagliflozin is a Sodium-Glucose Cotransporter 2 Inhibitor medication tracked in Medicare Part D.

Is there a generic for Sotagliflozin?

No. Sotagliflozin is brand-only with no generic equivalents currently in market.

How much does my plan pay for Sotagliflozin?

Across 329 Part D plans, Sotagliflozin averages $20.34/unit (NADAC). Lowest available: $20.34/unit. Highest in distribution: $20.34/unit.

Is Sotagliflozin on the FDA shortage list?

No. Sotagliflozin is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Sodium-Glucose Cotransporter 2 Inhibitor6 alternatives in D1
01
Bexagliflozin
Brand: BRENZAVVY
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Empagliflozin
Brand: JARDIANCE
$11.20Lowest NADAC
0Generic mfrs
$18.48BCY24 Part D spend
Compare →
03
Empagliflozin and Linagliptin
Brand: Glyxambi
$11.19Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Empagliflozin and Metformin
Brand: Synjardy
$5.60Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
05
Empagliflozin, Linagliptin, Metformin
Brand: Trijardy XR
$5.62Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
06
Empagliflozin, Metformin
Brand: Synjardy
$5.59Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (2 approvals on file) · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.